Delivering Over 5 Billion Doses of Biotherapeutics to Protect Animal Health Worldwide
In 2024, Cryoport Systems achieved a remarkable milestone: the delivery of over 5 billion doses of biotherapeutics, including cell-based therapies, antibody-based therapies, and vaccines to the global animal health industry. This achievement is the result of our unwavering commitment to ensuring the health and well-being of animals across the world, from livestock that sustain global food supply chains to the beloved companion animals that enrich our lives.
Supporting a Global Ecosystem of Farmers, Veterinarians, Owners, and Breeders
The demand for reliable, effective advanced therapies and vaccines in animal health has never been greater. Emerging diseases, evolving regulations, and an increasingly interconnected world present unique challenges to livestock producers, veterinarians, and pet owners alike. Our role in delivering billions of doses of various biotherapeutics has had a direct and lasting impact, providing critical treatments for and protection against diseases that threaten both economic stability and animal welfare.
The scale of our achievement would not have been possible without our world-class temperature-controlled supply chain solutions. Biologics like cell-based therapies require precise temperature control to maintain their efficacy. Our advanced cryogenic, ultra-cold, and refrigerated solutions ensure that every dose arrives in optimal condition, no matter the distance or environmental challenges.
Through our proprietary Chain of Compliance® process and near real-time monitoring within our Cryoportal® logistics management system, we provide end-to-end visibility, ensuring that sensitive, next-generation treatments and vaccines remain within required temperature ranges throughout the entire journey with the industry’s most rigorous quality standards. Whether delivering doses to rural farms, urban veterinary clinics, or international distribution hubs, our solutions guarantee product integrity and regulatory compliance at every step, with 24/7/365 monitoring of every shipment in transit by our team of experts.
Enabling Biosecurity and Disease Prevention on a Global Scale
Beyond logistics, our work plays a critical role in global biosecurity. With our proprietary Veri-Clean® process, we provide the industry’s most rigorous and validated decontamination for all our shipping systems and stainless-steel accessories. This process is critical for maintaining the integrity and safety of temperature-sensitive materials. Every shipping system undergoes the Veri-Clean® process every time it is returned, ensuring that all our shipping systems are provided in a superior, decontaminated state.
We understand the importance of biosecurity, and how the widespread availability of effective advanced therapies, biotherapeutics, and vaccines help prevent outbreaks that could devastate livestock populations and disrupt food supply chains. By ensuring timely and consistent delivery for sensitive therapeutics, we contribute to global disease control efforts, reducing the risks of cross-species transmission and safeguarding public health.
As we reflect on this milestone, we remain focused on the future. The global landscape of animal health is constantly evolving, and Cryoport Systems is committed to innovation and excellence in supply chain solutions. We will continue to invest in cutting-edge technologies, expand our global network, and collaborate with industry leaders to address emerging challenges in animal health logistics.
Delivering over 5 billion biotherapeutic doses in a single year is a testament to our expertise, dedication, and impact. But more importantly, it is a reflection of our mission to Enabling the Outcome by protecting the health of animals worldwide. Whether on farms, in homes, or in veterinary clinics, our work is making a difference, one dose at a time.
